| USGOV-DEPARTMENT-OF-DEFENSE |
USGOV-DEPARTMENT-OF-DEFENSE |
95%
|
USAspending awards from Department of Defense: $3,308,806 across 1 awards. HT001422C0003 PROSTHETIST, PROSTHETIST TECHNICIAN, AND PROSTHETIST ASSISTANT IN THE DEPARTMENT OF SURGICAL SERVICES AND REHA… |
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES |
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES |
95%
|
USAspending awards from Department of Health and Human Services: $1,880,220 across 7 awards. 75N95025F00002 CHROMIUM CELL KITS; 75N95025F00001 CHROMIUM CELL KITS; 75N95D25F40047 BIOLOGICAL REAGENT MA… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
95%
|
USAspending awards from Department of Veterans Affairs: $679,003 across 2 awards. 36C24224P1582 10X GENOMICS XENIUM ANALYZER/10X GENOMICS VISIUM CYTASSIST; 36C24225P1431 GENE EXPRESSION REAGENTS | Qw… |
| PACB |
Pacific Biosciences of California, Inc. |
72%
|
Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 a… |
| RSSS |
Research Solutions, Inc. |
72%
|
mpany operates as a single operating and reportable segment. The Company’s single reportable segment consists of its integrated research solutions, including instruments, consumables and related soft… |
| RSSS |
Research Solutions, Inc. |
72%
|
Reciprocal relationship from RSSS graph: Reciprocal relationship from TXG graph: mpany operates as a single operating and reportable segment. The Company’s single reportable segment consists of its i… |
| CENTRILLION-TECHNOLOGIES-INC |
CENTRILLION-TECHNOLOGIES-INC |
62%
|
Item 1A of our Annual Report. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information av… |
| CENTRILLION-TECHNOLOGY-HOLDINGS-CORP |
CENTRILLION-TECHNOLOGY-HOLDINGS-CORP |
62%
|
Item 1A of our Annual Report. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information av… |
| PARSE-BIOSCIENCES-INC |
PARSE-BIOSCIENCES-INC |
62%
|
ferred revenue related to extended warranty service agreements. Three Months Ended March 31, (in thousands) 2026 2025 Beginning of period $ 34,403 $ 33,171 Revenue recognized that was included in the… |
| SCALE-BIOSCIENCES-INC |
SCALE-BIOSCIENCES-INC |
62%
|
Item 1A of our Annual Report. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information av… |